For research use only. Not for therapeutic Use.
SU5208 inhibits vascular endothelial growth factor receptor-2 (VEGFR2)[1].
| Catalog Number | I044501 |
| CAS Number | 62540-08-3 |
| Synonyms | (3Z)-3-(thiophen-2-ylmethylidene)-1H-indol-2-one |
| Molecular Formula | C13H9NOS |
| Purity | ≥95% |
| InChI | InChI=1S/C13H9NOS/c15-13-11(8-9-4-3-7-16-9)10-5-1-2-6-12(10)14-13/h1-8H,(H,14,15)/b11-8- |
| InChIKey | QMTIIBUDOBNABZ-FLIBITNWSA-N |
| SMILES | C1=CC=C2C(=C1)C(=CC3=CC=CS3)C(=O)N2 |
| Reference | [1]. Camila Muñoz, et al. Study of differences in the VEGFR2 inhibitory activities between semaxanib and SU5205 using 3D-QSAR, docking, and molecular dynamics simulations. J Mol Graph Model. 2012 Feb;32:39-48. |
